Sun Xiao-Xin, Sears Rosalie C, Dai Mu-Shui
a Departments of Molecular & Medical Genetics ; School of Medicine and the OHSU Knight Cancer Institute; Oregon Health & Science University ; Portland , OR USA.
Cell Cycle. 2015;14(24):3786-93. doi: 10.1080/15384101.2015.1093713.
Ubiquitination plays a key and complex role in the regulation of c-Myc stability, transactivation, and oncogenic activity. c-Myc is ubiquitinated by a number of ubiquitin ligases (E3s), such as SCF(Fbw7) and SCF(Skp2). Depending on the E3s, ubiquitination can either positively or negatively regulate c-Myc levels and activity. Meanwhile, c-Myc ubiquitination can be reversed by deubiquitination. An early study showed that USP28 deubiquitinates c-Myc via interacting with Fbw7α whereas a recent study reveals that USP37 deubiquitinates c-Myc independently of Fbw7 and c-Myc phosphorylation. Consequently, both USP28 and USP37 stabilize c-Myc and enhance its activity. We recently found the nucleolar USP36 as a novel c-Myc deubiquitinase that controls the end-point of c-Myc degradation pathway in the nucleolus. Here we briefly review the current understanding of ubiquitination and deubiquitination regulation of c-Myc and further discuss the USP36-c-Myc regulatory pathway.
泛素化在c-Myc的稳定性、反式激活及致癌活性的调控中发挥着关键且复杂的作用。c-Myc可被多种泛素连接酶(E3)泛素化,如SCF(Fbw7)和SCF(Skp2)。根据不同的E3,泛素化可正向或负向调控c-Myc的水平及活性。同时,c-Myc的泛素化可通过去泛素化作用逆转。一项早期研究表明,USP28通过与Fbw7α相互作用使c-Myc去泛素化,而最近一项研究显示,USP37可独立于Fbw7及c-Myc磷酸化使c-Myc去泛素化。因此,USP28和USP37均可使c-Myc稳定并增强其活性。我们最近发现核仁中的USP36是一种新型的c-Myc去泛素酶,它控制着c-Myc在核仁中降解途径的终点。在此,我们简要回顾目前对c-Myc泛素化和去泛素化调控的认识,并进一步探讨USP36-c-Myc调控途径。